Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sergio Vázquez-Estévez"'
Autor:
Benito Blanco Gómez, Rubén López-Cortés, Francisco Javier Casas-Nebra, Sergio Vázquez-Estévez, Daniel Pérez-Fentes, María del Pilar Chantada-Vázquez, Susana B. Bravo, Cristina Núñez
Publikováno v:
Nanomaterials, Vol 11, Iss 9, p 2384 (2021)
Because cystoscopy is expensive and invasive, a new method of detecting non-invasive muscular bladder cancer (NMIBC) is needed. This study aims to identify potential serum protein markers for NMIBC to improve diagnosis and to find treatment approache
Externí odkaz:
https://doaj.org/article/1cac99148792456c9d0bfac74a306890
Autor:
María del Pilar Chantada-Vázquez, María García-Vence, Sergio Vázquez-Estévez, Susana B. Bravo, Cristina Núñez
Publikováno v:
Nanomaterials, Vol 10, Iss 6, p 1223 (2020)
It is well known that the interaction of a nanomaterial with a biological fluid leads to the formation of a protein corona (PC) surrounding the nanomaterial. Using standard blood analyses, alterations in protein patterns are difficult to detect. PC a
Externí odkaz:
https://doaj.org/article/a7d1093347b445529f74b4b96bf50404
Autor:
María P. Fernandez‐Perez, Enrique Perez‐Navarro, Teresa Alonso‐Gordoa, Vicenza Conteduca, Albert Font, Sergio Vázquez‐Estévez, Aránzazu González‐del‐Alba, Daniel Wetterskog, Emmanuel S. Antonarakis, Begona Mellado, Ovidio Fernandez‐Calvo, María J. Méndez‐Vidal, Miguel A. Climent, Ignacio Duran, Enrique Gallardo, Angel Rodriguez Sanchez, Carmen Santander, Maria I. Sáez, Javier Puente, Julian Tudela, Alberto Martínez, Maria J. López‐Andreo, José Padilla, Rebeca Lozano, David Hervas, Jun Luo, Ugo de Giorgi, Daniel Castellano, Gerhardt Attard, Enrique Grande, Enrique Gonzalez‐Billalabeitia
Publikováno v:
The Prostate. 83:376-384
Background There is a considerable need to incorporate biomarkers of resistance to new antiandrogen agents in the management of castration-resistant prostate cancer (CRPC). Methods We conducted a phase II trial of enzalutamide in first-line chemo-na
Autor:
Carlos Aguado de la Rosa, Patricia Cruz Castellanos, Martín Lázaro-Quintela, Manuel Dómine, Sergio Vázquez Estévez, Guillermo López-Vivanco, José Luis Fírvida Pérez, José Luis Alonso Romero, Lioba Ferrera Delgado, Carlos García Girón, Pilar Diz Taín, Rosa Álvarez Álvarez, Pilar Mut Sanchís, Inmaculada Fernández Cantón, Isabel Manrique Abós, Maite Martínez Aguillo, Lorenzo Gómez-Aldaraví Gutiérrez, Ana Laura Ortega Granados, Ruth Álvarez Cabellos, Arancha García Sebastián, Luis Fernando García Sifuentes, Noemí Reguart
Publikováno v:
Lung Cancer. 173:83-93
To determine the incidence of ALK translocations in patients with advanced/metastatic NSCLC in Spain, to describe the clinical characteristics of these patients, and to evaluate the effectiveness and safety of treatment with crizotinib in a real-worl
Autor:
Urbano Anido Herranz, Ovidio Fernandez Calvo, Sara Martinez Breijo, Natalia Fernández Núñez, Zulema Nogareda Seoane, Miguel Garrido Pumar, Javier Casas, Gloria Muñiz Garcia, Paula Portela Pereira, Antonio Gomez Caamaño, Daniel Pérez Fentes, Lucía Santomé, Gerardo Huidobro Vence, Aurea Molina Díaz, Ana Medina, Juan Ruiz Bañobre, Sergio Vázquez Estévez
Publikováno v:
Journal of Clinical Oncology. 41:96-96
96 Background: Radium-223 represents an option for symptomatic metastatic castration-resistant prostate cancer (mCRPC) after demonstrated an overall survival improvement in the ALSYMPCA trial. Radium-223 real-life experiences are scarce, particularly
Autor:
María del Pilar Chantada-Vázquez, Mercedes Conde-Amboage, Lucía Graña-López, Sergio Vázquez-Estévez, Susana B. Bravo, Cristina Núñez
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 1087
Despite the increasing use of neoadjuvant chemotherapy (NAC) in HER2-positive breast cancer (BC) patients, the clinical problem of predicting individual treatment response remains unanswered. Furthermore, the use of ineffective chemotherapeutic regim
Autor:
Sergio Vázquez Estévez, Carmen González Arenas, Jose Miguel Sanchez Torres, Juan Felipe Córdoba-Ortega, Jorge García González, Inmaculada Maestu Maiques, Javier Valdivia-Bautista, Martín Lázaro, Belen Rubio-Viqueira, Margarita Majem Tarruella, Ana Blasco Cordellat
Publikováno v:
Lung Cancer Management
Aim: To describe the clinical management and PD-L1 testing of patients with newly diagnosed stage IV non-small cell lung cancer (NSCLC) without driver mutations in Spain. Methods: Multicenter, retrospective study. Results: Among 297 evaluated patient
Autor:
Ricardo Hitt, Ricard Mesía, Alicia Lozano, Lara Iglesias Docampo, Juan J. Grau, Miren Taberna, Jordi Rubió-Casadevall, Javier Martínez-Trufero, Edel del Barco Morillo, Carlos García Girón, Sergio Vázquez Estévez, Beatriz Cirauqui, Juan Jesús Cruz-Hernández
Publikováno v:
Oral oncology. 134
Concurrent chemoradiotherapy is the standard treatment for patients with unresectable, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN); induction chemotherapy (ICT) may provide survival benefits in some patients. This study a
Autor:
Urbano Anido-Herranz, Ovidio Fernandez-Calvo, Juan Ruiz-Bañobre, Sara Martinez-Breijo, Natalia Fernandez-Nuñez, Zulema Nogareda-Seoane, Miguel Garrido-Pumar, Javier Casas-Nebra, Gloria Muñiz-Garcia, Paula Portela-Pereira, Antonio Gomez-Caamaño, Daniel Adolfo Perez-Fentes, Lucia Santome-Couto, Martín Lázaro, Aurea Molina-Diaz, Ana Medina-Colmenero, Sergio Vazquez-Estevez
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRadium-223 dichloride (Ra-223) is recommended as a treatment option for metastatic castration-resistant prostate cancer (mCRPC) patients with symptomatic bone metastases and no visceral disease, after docetaxel failure, or in patients who
Externí odkaz:
https://doaj.org/article/54152fa9facb47b9970ec092bda4d1a6
Publikováno v:
JBIC Journal of Biological Inorganic Chemistry. 23:331-345
Nanoparticles are being actively developed for biomolecular profiling of cancer biomarkers, tumor imaging in vivo, and targeted drug delivery. These nanotechnology-based techniques can be applied widely in the management of different malignant diseas